Bailey et al.
661
3.36, 5.80 Hz), 7.30–7.20 (m, 10H). 13C NMR (ppm,
CDCl3) δ: 183.0, 146.4, 139.6, 134.1, 132.2, 129.7, 128.3,
127.7, 127.3 (11 peaks predicted, 9 observed). MS (EI) m/z:
360 [M+].
8.34 (m, 4H), 7.82 (dd, 2H, J = 3.3, 5.8 Hz), 7.30–7.29 (m,
3H), 7.23 (dd, 2H, J = 3.0, 6.7 Hz), 7.14 (d, 2H, J = 8.7 Hz),
6.80 (d, 2H, J = 8.7 Hz), 3.80 (s, 3H). 13C NMR (ppm,
CDCl3) δ: 183.3, 183.2, 159.5, 146.5, 146.3, 140.1, 134.3,
134.3, 134.0, 133.9, 132.5, 132.1, 131.1, 130.0, 129.8,
129.7, 128.5, 127.8, 127.5, 113.9, 55.5 (23 peaks predicted,
21 observed). MS (EI) m/z: 390.4 [C27H18O3 , 100]. Ele-
mental anal. calcd. for C27H18O3: C 83.06, H 4.65; found: C
82.80, H 4.89.
2,3-Di(naphthalen-2-yl)anthraquinone (8)
+
2,3-Di(naphthalen-2-yl)anthraquinone (8) was prepared
from 4-hydroxy-3,4-di(naphthalen-2-yl)cyclopent-2-enone
(16) according to the method described previously. The
crude product was eluted through silica gel with a 1:1 mix-
ture of hexanes–toluene, and then recrystallized from etha-
nol to afford 0.055 g (0.13 mmol, 18%) of 8 as a yellow
2-(4-Bromophenyl)-3-(4-methoxyphenyl)anthraquinone (12)
2-(4-Bromophenyl)-3-(4-methoxyphenyl)anthraquinone (12)
was prepared from 3-(4-bromophenyl)-4-hydroxy-4-(4-
methoxyphenyl)cyclopent-2-enone/4-(4-bromophenyl)-4-
hydroxy-3-(4-methoxyphenyl)cyclopent-2-enone (23) ac-
cording to the method described previously. The product was
eluted through silica gel with toluene, then recrystallized
from ethanol to afford 0.120 g (0.26 mmol, 21%) of 12 as an
1
solid; mp: 238 °C. H NMR (ppm, CDCl3) δ: 8.53 (s, 2H),
8.38 (dd, 2H, J = 3.3, 5.8 Hz), 7.96 (s, 2H), 7.85 (dd, 2H,
J = 3.3, 5.8 Hz), 7.81 (dd, 2H, J = 3.4, 6.0 Hz), 7.76 (dd,
2H, J = 3.4, 6.0 Hz), 7.59 (d, 2H, J = 8.6 Hz), 7.48 (dd, 4H,
J = 3.2, 6.2 Hz), 7.17 (dd, 4H, J = 1.7, 8.5 Hz). 13C NMR
(ppm, CDCl3) δ: 183.0, 146.4, 137.3, 134.2, 133.8, 133.3,
132.6, 132.4, 130.1, 128.9, 128.3, 127.7, 127.4, 127.3,
126.5, 126.3 (17 peaks predicted, 16 observed). MALDI-
TOF m/z: 462 [M + 2, 100]. Elemental anal. calcd. for
C34H20O2: C 88.67, H 4.38; found: C 88.51, H 4.58.
1
orange solid; mp 215 to 216 °C. H NMR (ppm, CDCl3) δ:
8.34 (dd, 2H, J = 3.1, 5.4 Hz), 8.33 (s, 1H), 8.30 (s, 1H),
7.83 (dd, 2H, J = 3.3, 5.8 Hz), 7.43 (d, 2H, J = 8.4 Hz),
7.14–7.09 (m, 4H), 6.83 (d, 2H, J = 8.7 Hz), 3.82 (s, 3H).
13C NMR (ppm, CDCl3) δ: 183.2, 183.1, 159.6, 146.3,
145.1, 139.0, 134.4, 134.4, 133.9, 132.7, 132.2, 131.8,
131.7, 131.4, 131.1, 129.8, 129.7, 127.5, 122.3, 114.1, 55.5
(23 peaks predicted, 21 observed). MS (CI) m/z (relative in-
tensity): 468.2 (80%), 469.2 (60%), 470.2 (100%), 471.2
(58%), 472 (13%). Elemental anal. calcd. for C27H17BrO3: C
69.10, H 3.65; found: C 69.27, H 3.72.
2,3-Di(o-tolyl)anthraquinone (9)
2,3-Di(o-tolyl)anthraquinone (9) was prepared from 4-
hydroxy-3,4-di(o-tolyl)cyclopent-2-enone (17) according to
the method described previously. The crude product was
eluted through silica gel with toluene and recrystallized from
ethanol to yield 0.090 g (0.23 mmol, 17%) of 9 as an off-
1
white solid; mp 247 °C. H NMR (ppm, CDCl3) δ: 8.34 (dd,
2H, J = 3.3, 5.7 Hz), 8.28 (s, 2H), 7.82 (dd, 2H, J = 3.3,
5.7 Hz), 7.13–6.91 (broad m, 8H), 2.11 (s, 6H). 13C NMR
(ppm, CDCl3) δ: 183.1, 147.3 (broad), 139.1 (broad), 135.3,
134.1, 133.8, 131.9, 130.2, 129.8, 127.8, 127.2, 125.2, 20.2
(broad) (14 peaks predicted, 13 observed). MS (EI) m/z:
388.1 [M+, 100]. Elemental anal. calcd. for C28H20O2: C
86.57, H 5.19; found: C 86.38, H 5.27.
2-(4-Methoxyphenyl)-3,6,7-triphenylanthraquinone (24)
2-(4-Methoxyphenyl)-3,6,7-triphenylanthraquinone (24)
was prepared from 6,7-diphenyl-1,4-naphthoquinone and a
mixture of 21a and 21b. The crude product was purified
through silica gel with toluene as the eluent. Recrystalliza-
tion of this product from ethanol afforded 0.14
g
1
(0.26 mmol, 26%) of 24 as an orange solid; mp 230 °C. H
NMR (ppm, CDCl3) δ: 8.40 (s, 2H), 8.38 (d, 2H, J =
2.9 Hz), 7.31–7.23 (m, 15H), 7.17 (d, 2H, J = 8.8 Hz), 6.82
(d, 2H, J = 8.8 Hz), 3.81 (s, 3H). 13C NMR (ppm, CDCl3) δ:
183.1, 183.0, 159.5, 146.6, 146.6, 146.4, 146.3, 140.1,
139.9, 132.7, 136.7, 132.3, 132.1, 131.2, 130.0, 129.9,
129.8, 129.7, 128.5, 128.4, 127.9, 127.8, 113.9, 55.5 (31
peaks predicted, 24 observed). MALDI-TOF m/z: 543 [M+,
100]. Elemental anal. calcd. for C39H26O3: C 86.32, H 4.83;
found: C 85.97, H 5.03.
2,3-Bis(4-methoxyphenyl)anthraquinone (10)
2,3-Bis(4-methoxyphenyl)anthraquinone (10) was pre-
pared from 4-hydroxy-3,4-bis(4-methoxyphenyl)cyclopent-
2-enone (18) according to the method described previously.
The crude product was eluted through silica gel with a 4:1
mixture of hexanes – ethyl acetate as the eluent. The result-
ing product was recrystallized from ethanol to afford 0.04 g
1
(0.09 mmol, 7%) of 10 as a brown solid; mp 168 °C. H
NMR (ppm, CDCl3) δ: 8.34 (dd, 2H, J = 3.3, 5.8 Hz), 8.31
(s, 2H), 7.81 (dd, 2H, J = 3.3, 5.8 Hz), 7.16 (d, 4H, J =
8.7 Hz), 6.82 (d, 4H, J = 8.7 Hz), 3.82 (s, 6H). 13C NMR
(ppm, CDCl3) δ: 183.0, 159.2, 145.9, 134.0, 133.8, 132.1,
131.9, 130.9, 129.5, 127.2, 113.8, 55.2. MS (CI) m/z: 421.2,
422.1 [M + 1, 100] (29%). Elemental anal. calcd. for
C28H20O4: C 79.98, H 4.97; found: C 80.13, H 4.90.
2,3-Bis(4-methoxyphenyl)-6,7-diphenylanthraquinone (25)
2,3-Bis(4-methoxyphenyl)-6,7-diphenylanthraquinone (25)
was prepared from 6,7-diphenyl-1,4-napthoquinone (7) and
4-hydroxy-3,4-bis(4-methoxyphenyl)cyclopent-2-enone (18)
according to the method described previously. This mixture
of products was then purified through silica gel with a 4:1
mixture of hexanes – ethyl acetate as the eluent. The result-
ing solid was recrystallized from ethanol to afford 0.050 g
2-(4-Methoxyphenyl)-3-phenylanthraquinone (11)
1
2-(4-Methoxyphenyl)-3-phenylanthraquinone (11) was
prepared from a mixture of 21a and 21b according to the
method described previously. The crude product was eluted
through a silica gel column using toluene. Recrystallization
from ethanol afforded 0.087 g (0.22 mmol, 18%) of 11 as a
yellow solid; mp 89–91 °C. 1H NMR (ppm, CDCl3) δ: 8.36–
(0.09 mmol, 7%) of 25 as an orange solid; mp 235 °C. H
NMR (ppm, CDCl3) δ: 8.39 (s, 2H), 8.35 (s, 2H), 7.30–7.22
(m, 10H), 7.18 (d, 4H, J = 8.8 Hz), 6.83 (d, 4H, J = 8.7 Hz),
3.82 (s, 6H). 13C NMR (ppm, CDCl3) δ: 183.1, 159.4, 146.6,
146.1, 139.9, 132.7, 132.4, 132.3, 131.1, 129.9, 129.9,
129.8, 128.4, 127.9, 114.0, 55.5. MALDI-TOF m/z: 584
© 2006 NRC Canada